• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

俄罗斯和那乃族人群中 、 、 、 及 基因多态性频率的比较 。 (你原文中这几个基因名称处是缺失具体内容的哦)

Comparison of , , , , and gene-polymorphism frequency in Russian and Nanai populations.

作者信息

Sychev Dmitrij Alekseevitch, Shuev Grigorij Nikolaevich, Suleymanov Salavat Shejhovich, Ryzhikova Kristina Anatol'evna, Mirzaev Karin Badavievich, Grishina Elena Anatol'evna, Snalina Natalia Evgenievna, Sozaeva Zhannet Alimovna, Grabuzdov Anton Mikhailovich, Matsneva Irina Andreevna

机构信息

Department of Internal Medicine and Clinical Pharmacology, Russian Medical Academy of Continuing Professional Education, Ministry of Healthcare, Moscow.

Saiko Russian-Japanese Medical Center, Khabarovsk.

出版信息

Pharmgenomics Pers Med. 2017 Mar 31;10:93-99. doi: 10.2147/PGPM.S129665. eCollection 2017.

DOI:10.2147/PGPM.S129665
PMID:28435307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5386602/
Abstract

BACKGROUND

The efficiency and safety of drug therapy depends on the peculiarities of functioning of the P450 cytochrome group and transporting proteins. There are significant differences for single-nucleotide polymorphism (SNP) frequency.

MATERIALS AND METHODS

We studied the peculiarities of P450 cytochrome polymorphisms, SLCO1B1 transporting protein, and P-glycoprotein carriage in healthy volunteers in the Nanai ethnic group living in Russia, and compared them to the carriage of SNPs in the Russian population according to literature data.

RESULTS

After performing the real-time polymerase chain reactions on the samples from 70 healthy volunteers from the Nanai group, for the polymorphism we determined 70 CC-genotype carriers. As for the polymorphism, we found 62 AA-genotype carriers and eight AC-genotype carriers. For the polymorphism, we determined 39 GG-genotype carriers and 28 GA-genotype carriers, for the polymorphism 58 GG-genotype carriers and 12 GA-genotype carriers, and for the polymorphism 67 CC-genotype carriers and three CT-genotype carriers. For the polymorphism, the GG genotype had 68 carriers, and the GA genotype two carriers. For the polymorphism, there were 19 CC-genotype carriers and 39 CT-genotype carriers. For the polymorphism, the TT genotype had 41 carriers and the CT genotype 25 carriers. The distribution of genotypes fitted the Hardy-Weinberg equilibrium for all the polymorphisms, except those of . There were also significant differences in allele frequencies for some polymorphisms between the Nanais and the Russians.

CONCLUSION

In the Nanai population, there are polymorphisms connected with the decrease in safety and efficiency of drug therapy. Studying the ethnic differences might influence the determination of priority in the introduction of pharmacogenetic tests in clinical practice in different regions of Russia.

摘要

背景

药物治疗的有效性和安全性取决于细胞色素P450组和转运蛋白的功能特性。单核苷酸多态性(SNP)频率存在显著差异。

材料与方法

我们研究了居住在俄罗斯的那乃族健康志愿者中细胞色素P450多态性、SLCO1B1转运蛋白和P-糖蛋白携带情况,并根据文献数据将其与俄罗斯人群中的SNP携带情况进行比较。

结果

对来自那乃族的70名健康志愿者的样本进行实时聚合酶链反应后,对于 多态性,我们确定了70名CC基因型携带者。至于 多态性,我们发现62名AA基因型携带者和8名AC基因型携带者。对于 多态性,我们确定了39名GG基因型携带者和28名GA基因型携带者,对于 多态性,58名GG基因型携带者和12名GA基因型携带者,对于 多态性,67名CC基因型携带者和3名CT基因型携带者。对于 多态性,GG基因型有68名携带者,GA基因型有2名携带者。对于 多态性,有19名CC基因型携带者和39名CT基因型携带者。对于 多态性,TT基因型有41名携带者,CT基因型有25名携带者。除 多态性外,所有多态性的基因型分布均符合哈迪-温伯格平衡。那乃族和俄罗斯人在某些多态性的等位基因频率上也存在显著差异。

结论

在那乃族人群中,存在与药物治疗安全性和有效性降低相关的多态性。研究种族差异可能会影响俄罗斯不同地区临床实践中引入药物遗传学检测的优先级确定。

相似文献

1
Comparison of , , , , and gene-polymorphism frequency in Russian and Nanai populations.俄罗斯和那乃族人群中 、 、 、 及 基因多态性频率的比较 。 (你原文中这几个基因名称处是缺失具体内容的哦)
Pharmgenomics Pers Med. 2017 Mar 31;10:93-99. doi: 10.2147/PGPM.S129665. eCollection 2017.
2
Genetic Polymorphisms of Cytochrome P450 Enzymes and Transport Proteins in a Russian Population and Three Ethnic Groups of Dagestan.俄罗斯人群及达吉斯坦三个民族细胞色素P450酶和转运蛋白的基因多态性
Genet Test Mol Biomarkers. 2017 Dec;21(12):747-753. doi: 10.1089/gtmb.2017.0036. Epub 2017 Oct 12.
3
CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population.土耳其人群中CYP2C9、CYPC19和CYP2D6基因谱以及药物反应和毒性的基因易感性
Saudi Pharm J. 2017 Mar;25(3):376-380. doi: 10.1016/j.jsps.2016.09.003. Epub 2016 Sep 17.
4
Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.不丹人群中CYP2C9、CYP2C19、CYP2D6和CYP3A5的药物遗传学相关多态性
Drug Metab Pers Ther. 2019 Dec 18;34(4). doi: 10.1515/dmpt-2019-0020.
5
Clinically relevant pharmacogenetic markers in Tatars and Balkars.鞑靼人和巴尔卡尔人中与临床相关的遗传药理学标记物。
Mol Biol Rep. 2020 May;47(5):3377-3387. doi: 10.1007/s11033-020-05416-4. Epub 2020 Apr 17.
6
Frequency distribution of polymorphisms of CYP2C19, CYP2C9, VKORC1 and SLCO1B1 genes in the Yakut population.雅库特人群中CYP2C19、CYP2C9、VKORC1和SLCO1B1基因多态性的频率分布
Res Pharm Sci. 2016 May-Jun;11(3):259-64.
7
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.意大利人群中CYP2C9、CYP2C19和CYP2D6的等位基因及基因型频率
Pharmacol Res. 2004 Aug;50(2):195-200. doi: 10.1016/j.phrs.2004.01.004.
8
The frequency of CYP2C9, VKORC1, and CYP4F2 polymorphisms in Russian patients with high thrombotic risk.俄罗斯高血栓形成风险患者中CYP2C9、VKORC1和CYP4F2基因多态性的频率
Medicina (Kaunas). 2013;49(12):517-21.
9
Interethnic differences in the prevalence of main cardiovascular pharmacogenetic biomarkers.主要心血管药物遗传生物标志物患病率的种族间差异。
Pharmacogenomics. 2020 Jul;21(10):677-694. doi: 10.2217/pgs-2020-0005. Epub 2020 Jun 16.
10
CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.阿什肯纳兹犹太人群体中CYP2C9、CYP2C19和CYP2D6等位基因频率
Pharmacogenomics. 2007 Jul;8(7):721-30. doi: 10.2217/14622416.8.7.721.

引用本文的文献

1
Transplacental Therapeutic Drug Monitoring in Pregnant Women with Fetal Tachyarrhythmia Using HPLC-MS/MS.采用 HPLC-MS/MS 技术对胎儿心动过速孕妇进行胎盘内治疗药物监测。
Int J Mol Sci. 2023 Jan 17;24(3):1848. doi: 10.3390/ijms24031848.
2
The association of adjusted plasma valproic acid concentration with gene polymorphism in patients with epilepsy: a systematic review and meta-analysis.癫痫患者中校正血浆丙戊酸浓度与基因多态性的关联:一项系统评价和荟萃分析。
Ann Transl Med. 2021 May;9(10):846. doi: 10.21037/atm-21-1459.
3
Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications.药物遗传学研究中种族和民族分类的不一致性及其潜在的临床意义。
Pharmgenomics Pers Med. 2019 Jul 2;12:107-123. doi: 10.2147/PGPM.S207449. eCollection 2019.
4
Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis.俄罗斯人群中达比加群安全性的遗传决定因素(CES1 基因 rs2244613 多态性):多民族分析。
Mol Biol Rep. 2019 Jun;46(3):2761-2769. doi: 10.1007/s11033-019-04722-w. Epub 2019 Mar 8.

本文引用的文献

1
Drug Metabolism in the Liver.肝脏中的药物代谢。
Clin Liver Dis. 2017 Feb;21(1):1-20. doi: 10.1016/j.cld.2016.08.001. Epub 2016 Oct 15.
2
Pharmacogenetics in Oral Antithrombotic Therapy.口服抗血栓治疗中的药物遗传学
Clin Lab Med. 2016 Sep;36(3):461-72. doi: 10.1016/j.cll.2016.05.002. Epub 2016 Jun 15.
3
Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.个性化精准医学中的药物遗传学基础
Clin Lab Med. 2016 Sep;36(3):447-59. doi: 10.1016/j.cll.2016.05.006. Epub 2016 Jul 2.
4
Frequency distribution of polymorphisms of CYP2C19, CYP2C9, VKORC1 and SLCO1B1 genes in the Yakut population.雅库特人群中CYP2C19、CYP2C9、VKORC1和SLCO1B1基因多态性的频率分布
Res Pharm Sci. 2016 May-Jun;11(3):259-64.
5
The frequency of SLCO1B1*5 polymorphism genotypes among Russian and Sakha (Yakutia) patients with hypercholesterolemia.俄罗斯和萨哈(雅库特)地区高胆固醇血症患者中SLCO1B1*5基因多态性基因型的频率。
Pharmgenomics Pers Med. 2016 May 25;9:59-63. doi: 10.2147/PGPM.S99634. eCollection 2016.
6
Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes.CYP2C9基因和表型的全球种族间变异性及地理分布。
Expert Opin Drug Metab Toxicol. 2015;11(12):1893-905. doi: 10.1517/17425255.2015.1111871. Epub 2015 Nov 23.
7
Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.全球人群中CYP2C19等位基因、“预测”表型及“测量”代谢表型的种族间差异。
Pharmacogenomics J. 2016 Apr;16(2):113-23. doi: 10.1038/tpj.2015.70. Epub 2015 Oct 27.
8
The frequency of CYP2C19 genetic polymorphisms in Russian patients with peptic ulcers treated with proton pump inhibitors.俄罗斯接受质子泵抑制剂治疗的消化性溃疡患者中CYP2C19基因多态性的频率。
Pharmgenomics Pers Med. 2015 May 27;8:111-4. doi: 10.2147/PGPM.S78986. eCollection 2015.
9
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.临床药物基因组学实施联盟(CPIC)关于CYP2D6和CYP2C19基因分型与选择性5-羟色胺再摄取抑制剂给药的指南。
Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29.
10
[CYP2D6, CYP3A5, and CYP3A4 gene polymorphism in Russian, Tatar, and Bashkir populations].[俄罗斯、鞑靼和巴什基尔人群中的CYP2D6、CYP3A5和CYP3A4基因多态性]
Genetika. 2015 Jan;51(1):109-19.